**Question:** The serum tumor marker for trophoblastic tumor is:

A. Human Chorionic Gonadotropin (hCG)
B. Beta-hCG
C. Human Epididymis Protein 4 (HE4)
D. Carcinoembryonic Antigen (CEA)

**Core Concept:** Trophoblastic tumors are a type of malignant neoplasm that arises from the trophoblast cells, which are the precursor cells to the placenta. These cells are responsible for producing human chorionic gonadotropin (hCG) and beta-human chorionic gonadotropin (beta-hCG), which serve as tumor markers for monitoring the progression of trophoblastic tumors.

**Correct Answer: B. Beta-hCG**

**Why the Correct Answer is Right:** Beta-hCG is a more specific tumor marker for trophoblastic tumors compared to hCG, as it is less prone to interferences from normal physiological levels of hCG. Beta-hCG is released after the cleavage of hCG in the liver, which reduces the interference from normal hCG levels. Beta-hCG is useful in monitoring the response to treatment and predicting the prognosis of trophoblastic tumors.

**Why Each Wrong Option is Incorrect:**

A. Human Chorionic Gonadotropin (hCG): While hCG is a general marker for trophoblastic tumors, beta-hCG is a more specific marker due to the cleavage of hCG in the liver, which reduces interferences from normal hCG levels.

B. Carcinoembryonic Antigen (CEA): CEA is a tumor marker for gastrointestinal and colorectal cancers, not specifically for trophoblastic tumors.

C. Human Epididymis Protein 4 (HE4): HE4 is a tumor marker for ovarian and breast cancers, not specifically for trophoblastic tumors.

D. Alpha-fetoprotein (AFP): AFP is a marker for hepatocellular carcinoma, neuroblastoma, and yolk sac tumors, not specifically for trophoblastic tumors.

**Clinical Pearl:** In cases of suspected trophoblastic tumors, measuring beta-hCG levels in serum is crucial for diagnosing, monitoring the response to treatment, and predicting prognosis.